- Home
- TAK vs GM Comparison
TAK vs GM Comparison
Compare TAK & GM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- GM
- Stock Information
- Founded
- TAK 1781
- GM 1908
- Country
- TAK Japan
- GM United States
- Employees
- TAK N/A
- GM N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- GM Auto Manufacturing
- Sector
- TAK Health Care
- GM Consumer Discretionary
- Exchange
- TAK Nasdaq
- GM Nasdaq
- Market Cap
- TAK 47.5B
- GM 50.5B
- IPO Year
- TAK N/A
- GM N/A
- Fundamental
- Price
- TAK $14.49
- GM $54.49
- Analyst Decision
- TAK
- GM Buy
- Analyst Count
- TAK 0
- GM 17
- Target Price
- TAK N/A
- GM $55.65
- AVG Volume (30 Days)
- TAK 5.7M
- GM 10.1M
- Earning Date
- TAK 07-30-2025
- GM 07-22-2025
- Dividend Yield
- TAK 3.76%
- GM 1.12%
- EPS Growth
- TAK N/A
- GM N/A
- EPS
- TAK 0.59
- GM 6.24
- Revenue
- TAK $31,053,301,865.00
- GM $187,600,000,000.00
- Revenue This Year
- TAK $0.47
- GM N/A
- Revenue Next Year
- TAK $0.80
- GM N/A
- P/E Ratio
- TAK $47.52
- GM $8.58
- Revenue Growth
- TAK 1.52
- GM 5.34
- 52 Week Low
- TAK $12.80
- GM $41.09
- 52 Week High
- TAK $15.53
- GM $61.24
- Technical
- Relative Strength Index (RSI)
- TAK 49.01
- GM 56.93
- Support Level
- TAK $13.49
- GM $52.09
- Resistance Level
- TAK $14.29
- GM $53.33
- Average True Range (ATR)
- TAK 0.22
- GM 1.48
- MACD
- TAK 0.03
- GM -0.08
- Stochastic Oscillator
- TAK 69.71
- GM 80.01
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About GM General Motors Company
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2024's share was 17.0%. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.